Michael Arad
Impact in
-
- Cardiomyopathy and Myosin Studies
- Cardiac electrophysiology and arrhythmias
- Pericarditis and Cardiac Tamponade
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Heart Failure Treatment and Management
- Molecular Biology top 2%
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Metabolism, Diabetes, and Cancer
Papers in
-
- Cardiomyopathy and Myosin Studies 59
- Cardiac electrophysiology and arrhythmias 34
- Heart Failure Treatment and Management 13
- Pericarditis and Cardiac Tamponade 10
- Rheumatology 11
- Glycogen Storage Diseases and Myoclonus 10
- Co-authors
- Jonathan G. Seidman (27 shared papers)Christine E. Seidman (26 shared papers)Antonio R. Pérez‐Atayde (7 shared papers)Ronald J. Kanter (4 shared papers)Edith Hochhauser (29 shared papers)William John McKenna (6 shared papers)Dov Freimark (35 shared papers)Maayan Waldman (15 shared papers)
- Journals
- European Heart Journal (13 papers)Heart Rhythm (7 papers)Journal of the American College of Cardiology (7 papers)Circulation (7 papers)International Journal of Cardiology (6 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Michael Arad
204 papers receiving 12.7k citations
Michael Arad's Hit Papers
Peers
Comparison fields: 5 of 127
- Cardiology and Cardiovascular Medicine 8.3k
- Molecular Biology 2.5k
- Rheumatology 460
- Geriatrics and Gerontology 102
- Physiology 676
Countries citing papers authored by Michael Arad
This map shows the geographic impact of Michael Arad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Arad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Arad more than expected).
Fields of papers citing papers by Michael Arad
This network shows the impact of papers produced by Michael Arad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Arad. The network helps show where Michael Arad may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Arad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 ESC Guidelines for the diagnosis and management of pericardial diseases Hit paper breakdown → | 2015 | 1702 |
| 2 | 2023 ESC Guidelines for the management of cardiomyopathies Hit paper breakdown → | 2023 | 1503 |
| 3 | Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 868 |
| 4 | Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases Hit paper breakdown → | 2021 | 788 |
| 5 | 2005 | 517 | |
| 6 | 2002 | 397 | |
| 7 | Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies Hit paper breakdown → | 2016 | 384 |
| 8 | 2010 | 379 | |
| 9 | 2002 | 371 | |
| 10 | 2007 | 305 | |
| 11 | Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology Hit paper breakdown → | 2019 | 281 |
| 12 | 2003 | 278 | |
| 13 | Diagnosis and Treatment of Cardiac Amyloidosis. A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Hit paper breakdown → | 2021 | 254 |
| 14 | 2017 | 205 | |
| 15 | Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Hit paper breakdown → | 2024 | 187 |
| 16 | 2005 | 172 | |
| 17 | 2020 | 168 | |
| 18 | 2002 | 153 | |
| 19 | 2007 | 153 | |
| 20 | 2018 | 153 |
About Michael Arad
Michael Arad is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology, Molecular Biology, Pathology and Forensic Medicine and Occupational Therapy, having authored 211 papers that have together received 13.3k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (59 papers), Cardiac electrophysiology and arrhythmias (34 papers), Heart Failure Treatment and Management (13 papers), Cardiac Ischemia and Reperfusion (11 papers), Pericarditis and Cardiac Tamponade (10 papers), Glycogen Storage Diseases and Myoclonus (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Pluripotent Stem Cells Research (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.3k citations), Molecular Biology (2.5k citations), Rheumatology (460 citations), Geriatrics and Gerontology (102 citations) and Physiology (676 citations). Michael Arad has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Jonathan G. Seidman, Christine E. Seidman, Antonio R. Pérez‐Atayde, Ronald J. Kanter, Edith Hochhauser, William John McKenna, Dov Freimark, Maayan Waldman, Elizabeth A. Sparks and D. Woodrow Benson. Their work appears in journals such as European Heart Journal, Heart Rhythm, Journal of the American College of Cardiology, Circulation and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.